Skip to main content

Publisher: Palgrave Macmillan

Volume 10, Number 1, 1 September 2003

Favourites:
ADD
Favourites:
ADD

Commercial biotechnology in Germany: An overview
pp. 15-21(7)
Authors: Bialojan, Siegfried; Schüler, Julia

Favourites:
ADD
Favourites:
ADD

Riposte: FDA response to ‘Yin, yang and the biopharmaceutical industry’
pp. 36-39(4)
Authors: Rosenberg, Amy S; Weiss, Karen D; Lanthier, Michael; Eastep, Roger; Egan, William; Goodman, Jesse L; Woodcock, Janet

Favourites:
ADD

The impact of pharmacogenetics and pharmacogenomics
pp. 60-77(18)
Author: Lindpaintner, Klaus

Favourites:
ADD

A new model to evaluate the market for biotechnology
pp. 78-84(7)
Authors: McMurray, Amanda; Jones, Richard

Favourites:
ADD

Biotechnology M&A insight: Deals and strategies
pp. 85-91(7)
Author: Pavlou, Alex K

Favourites:
ADD

Financial accounts reports
pp. 104-106(3)
Author: Citron, David

Favourites:
ADD

Biotech Alliances: Bridging the R&D Gap
pp. 107-108(2)
Author: Scott, Nerida

Favourites:
ADD

Additional on-line material: Pharmacoeconomics and the growth of the biotechnology industry
pp. 109-120(12)
Authors: Szucs, Thomas D; Schneeweiss, Sebastian

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more